Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-19 4:30 pm Purchase | 2022-09-09 | 13G | SpringWorks Therapeutics, Inc. SWTX | Boxer Capital LLC | 3,421,541 5.700% | 3,421,541 (New Position) | Filing History |
| 2022-06-15 7:11 pm Unchanged | 2022-06-13 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital LLC | 6,323,359 15.100% | 0 (Unchanged) | Filing History |
| 2022-05-11 5:14 pm Sale | 2022-05-09 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 2,154,058 6.100% | -988,000 (-31.44%) | Filing History |
| 2022-03-18 9:00 pm Sale | 2022-03-17 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 3,142,058 8.900% | -575,201 (-15.47%) | Filing History |
| 2022-02-14 4:54 pm Sale | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 2,238,861 7.500% | -238,333 (-9.62%) | Filing History |
| 2022-02-14 4:47 pm Unchanged | 2021-12-31 | 13G | Atreca, Inc. BCEL | Boxer Capital LLC | 2,202,333 7.200% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:43 pm Sale | 2021-12-31 | 13G | Matinas BioPharma Holdings, Inc. MTNB | Boxer Capital LLC | 0 0.000% | -229,573 (Position Closed) | Filing History |
| 2022-02-14 4:40 pm Sale | 2021-12-31 | 13G | Solid Biosciences Inc. SLDB | Boxer Capital LLC | 355,735 4.700% | -57,615 (-13.94%) | Filing History |
| 2022-02-14 4:40 pm Sale | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Boxer Capital LLC | 4,082,576 3.600% | -6,226,674 (-60.40%) | Filing History |
| 2022-02-14 4:40 pm Sale | 2021-12-31 | 13G | Cabaletta Bio, Inc. CABA | Boxer Capital LLC | 540,000 1.900% | -1,063,361 (-66.32%) | Filing History |
| 2022-02-14 4:36 pm Sale | 2021-12-31 | 13G | DBV Technologies S.A. DBVT | Boxer Capital LLC | 53,365 1.900% | -135,000 (-71.67%) | Filing History |
| 2022-02-14 4:33 pm Sale | 2021-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY | Boxer Capital LLC | 0 0.000% | -1,675,377 (Position Closed) | Filing History |
| 2022-02-14 4:28 pm Sale | 2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Boxer Capital LLC | 0 0.000% | -1,200,000 (Position Closed) | Filing History |
| 2022-02-14 4:22 pm Sale | 2021-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | Boxer Capital LLC | 0 0.000% | -4,000,000 (Position Closed) | Filing History |
| 2022-02-14 4:21 pm Sale | 2021-12-31 | 13G | Elevation Oncology, Inc. ELEV | Boxer Capital LLC | 872,780 3.800% | -468,750 (-34.94%) | Filing History |
| 2022-02-14 4:19 pm Sale | 2021-12-31 | 13G | F-star Therapeutics, Inc. FSTX | Boxer Capital LLC | 0 0.000% | -1,501,428 (Position Closed) | Filing History |
| 2022-02-14 4:17 pm Purchase | 2021-12-31 | 13G | Therapeutics Acquisition Corp. RACA | Boxer Capital LLC | 2,500,000 2.800% | 1,000,000 (+66.67%) | Filing History |
| 2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 2,838,236 6.300% | 570,000 (+25.13%) | Filing History |
| 2022-02-14 4:14 pm Sale | 2021-12-31 | 13G | Talis Biomedical Corporation TLIS | Boxer Capital LLC | 0 0.000% | -103,400 (Position Closed) | Filing History |
| 2022-02-14 4:10 pm Sale | 2021-12-31 | 13G | Biomea Fusion, Inc. BMEA | Boxer Capital LLC | 1,188,405 4.100% | -900,000 (-43.10%) | Filing History |